Title : BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.

Pub. Date : 2021 Feb 10

PMID : 33568627






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
2 The cisplatin-induced up-regulation of BCAT1 decreased the cisplatin sensitivity by regulating autophagy through the mTOR signaling pathway. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
3 The cisplatin-induced up-regulation of BCAT1 decreased the cisplatin sensitivity by regulating autophagy through the mTOR signaling pathway. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
4 In addition, branched-chain amino acids or leucine treatment inhibited cisplatin- or BCAT1-mediated autophagy and increased cisplatin sensitivity by activating mTOR signaling in cancer cells. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
5 These findings demonstrate a new mechanism, revealing that BCAT1 decreases cisplatin sensitivity in cancer cells by inducing mTOR-mediated autophagy via branched-chain amino acid leucine metabolism, providing an attractive pharmacological target to improve the effectiveness of chemotherapy. Cisplatin mechanistic target of rapamycin kinase Homo sapiens